Keeler Thomas Management’s Medtronic MDT Stock Holding History

Keeler Thomas Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,794	Closed	-$373K	–	80
2022 Q4	$373K	Sell	4,794 -366	-7%	-$29.7K	0.19%	66
2022 Q3	$416K	Sell	5,160 -215	-4%	-$19.3K	0.21%	52
2022 Q2	$482K	Sell	5,375 -695	-11%	-$70.4K	0.24%	52
2022 Q1	$673K	Buy	6,070 +1,189	+24%	+$126K	0.32%	45
2021 Q4	$504K	Sell	4,881 -25,566	-84%	-$2.96M	0.22%	57
2021 Q3	$3.82M	Buy	30,447 +798	+3%	+$103K	1.82%	24
2021 Q2	$3.68M	Buy	29,649 +591	+2%	+$74.2K	1.8%	26
2021 Q1	$3.43M	Buy	29,058 +3,586	+14%	+$420K	1.81%	29
2020 Q4	$2.98M	Buy	+25,472	New	+$2.8M	1.68%	25

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Keeler Thomas Management's MDT Position: Q1 2023 in Review

Keeler Thomas Management sold out of Medtronic (MDT) in Q1 2023, closing a stake of 4,794 shares — an estimated $373K sold.

Keeler Thomas Management first reported a position in MDT in Q4 2020 and held it in 9 quarters. The position peaked at $3.82M in Q3 2021. 1,991 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

Keeler Thomas Management reported no remaining Medtronic position as of Q1 2023 after selling out during the quarter.
Keeler Thomas Management sold 4,794 Medtronic shares in Q1 2023, an estimated $373K.
Keeler Thomas Management first reported a position in Medtronic in Q4 2020 and held it in 9 quarters.
Keeler Thomas Management's Medtronic position peaked at $3.82M in Q3 2021.
1,991 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on Keeler Thomas Management's 13F filing for Q1 2023, filed 2 May 2023.